Researchers have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has also shown how these problematic B cells can be selectively targeted in a way that reduces the damaging autoimmune response of multiple sclerosis.
Mechanisms for selective multiple sclerosis treatment strategy
- Post author:
- Post published:May 29, 2024
- Post category:News Feed
- Post comments:0 Comments